Physician profile
Eric A Marcotte
NPI 1184757254
$1,853.76
in general payments reported to CMS, 2019-2025
23 companies · $32.67 in 2025
The $32.67 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $64.53 · 2021: $283 · 2022: $862 · 2023: $186 · 2024: $71.34 · 2025: $32.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $648.89 | 2022 | |
| Abbvie INC. | $570.37 | 2020-2025 | |
| Glaxosmithkline, LLC. | $77.18 | 2019-2024 | Shingrix, Arexvy |
| Pfizer INC. | $76.06 | 2019 | |
| Lilly USA, LLC | $57.96 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.85 | 2019 | |
| Merck Sharp & Dohme LLC | $51.21 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.64 | 2021 | |
| Stryker Corporation | $32.42 | 2022 | |
| Nevro Corp. | $30.98 | 2022 | |
| Abbott Laboratories | $25.82 | 2024 | I-Stat |
| Sanofi-Aventis U.S. LLC | $24.07 | 2019 | |
| Amgen INC. | $22.10 | 2019 | |
| Novo Nordisk INC | $20.89 | 2019 | |
| Medtronic USA, INC. | $17.55 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $16.99 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.92 | 2022 | |
| Amarin Pharma, INC. | $13.40 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.19 | 2022 | |
| Dexcom, INC. | $13.11 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.38 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $11.88 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Marcotte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.